Navigation Links
PDL BioPharma Announces Second Quarter 2009 Financial Results
Date:7/30/2009

humanized antibody products launched before patent expiry in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-looking Statements

This press release contains forward-looking statements, including PDL's expectations with respect to its 2009 royalty revenues, expenses, net income and cash provided by operating activities.

Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

  • The expected rate of growth in royalty-bearing product sales by PDL's existing licensees;
  • The relative mix of royalty-bearing products manufactured and sold outside the U.S. versus manufactured or sold in the U.S.;
  • The ability of our licensees to receive regulatory approvals to market and launch new royalty-bearing products and whether such products, if launched, will be commercially successful;
  • Changes in any of the other assumptions on which PDL's projected royalty revenues are based;
  • The outcome of pending litigation or disputes; and
  • The failure of licensees to comply with existing license agreements, including any failure to pay royalties due.

Other factors that may cause PDL's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are discussed in PDL's filings with the SEC, including the "Risk Factors" sections of its annual and quarterly reports filed with the SEC. Copies of PDL's filings with the SEC may be obtained at the "Investors" section of PDL
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009
2. DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
3. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
4. Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
5. Sinobiopharma Receives Trademark Approval and Authentication From Chinese Government For Its Tai Drug Series
6. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
7. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
8. PDL BioPharma Announces Record Date for October 1 Dividend Payment
9. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
10. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
11. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Food and Health Bureau has invited expressions of interest ... private hospitals at four sites in the Hong Kong ... March 31, 2010. ,, At a press conference, ... said the promotion of private hospital development was one ... Hong Kong government policy announced by Chief Executive Donald ...
(Date:12/15/2009)... Lupus Foundation of America and the Saint Thomas, Lupus ... Julian Lennon, son of the legendary John Lennon, and ... "LUCY," to raise funds for research on the disease ... of the proceeds from downloading "LUCY" at iTunes will ... and the Saint Thomas, Lupus Trust in Great Britain. ...
(Date:12/15/2009)... where all couples of reproductive age were evaluated, Italian ... The number of children born with cystic fibrosis decreases ... mutation carriers increases, a new study finds. , CF ... northeast Italy for many years. Since the 1990s, the ... number of infants born with CF. , Two different ...
(Date:12/15/2009)... needed for protection, CDC says, , , TUESDAY, Dec. 15 ... swine flu vaccine have been recalled by manufacturer Sanofi ... health officials said Tuesday. , According to the U.S. ... testing of the vaccine for children aged 6 months ... lower than required potency levels. "This means that doses ...
(Date:12/15/2009)... to be leaders in the fight against malaria ... experts in online learning, the Masie Center and ... -- ONE and Malaria No More ... first-ever "Malaria Griots" program, a dynamic education course ... leaders in the fight against malaria. ,, ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... Mass. - A new paper published in the latest ... Medical Internet Research evaluates consumers, experiences with the ... system developed by researchers in the Children,s Hospital Informatics ... been adapted by PCHR providers including Dossia, Microsoft and ...
... source of outbreak -- reports leveling off of cases , , ... swine flu cases in the United States has surpassed 100, ... be mild. , In response to the outbreak, scientists are ... never-before-seen flu strain, but the shots -- if needed at ...
... The Female Health Company (NYSE Amex: FHC ) ... to discuss its operating results for the second quarter and ... on Friday, May 8, 2009. The Company expects to ... results earlier the same day. Shareholders and other interested parties ...
... Pharmaceuticals International (NYSE: VRX ) today announced members ... the Bank of America and Merrill Lynch 2009 Health Care ... The conference will be held at The Palace Hotel in ... presentation will be available on the company,s Web site at ...
... -- Three Roche employees were recognized ... Jersey at the 2009 TWIN Awards Dinner held ... J.D., senior counsel and managing attorney; Theresa Martinez, ... Pegasys(R) (peginterferon alfa-2a); and Linda Lee-Mathieson, Director, Clinical ...
... Gaiam, Inc. (Nasdaq: GAIA ), a ... and services to customers who value personal development, wellness, ... results for the first quarter ended March 31, 2009 ... 2009. The Company will hold a teleconference to discuss ...
Other Medicine News:Health News:New study evaluates community response to personally controlled health information 2Health News:New study evaluates community response to personally controlled health information 3Health News:Swine Flu Infections Near 110 in U.S. 2Health News:Swine Flu Infections Near 110 in U.S. 3Health News:Swine Flu Infections Near 110 in U.S. 4Health News:Swine Flu Infections Near 110 in U.S. 5Health News:Swine Flu Infections Near 110 in U.S. 6Health News:Swine Flu Infections Near 110 in U.S. 7Health News:The Female Health Company Schedules Second Quarter Conference Call for May 8, 2009 2Health News:Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 2Health News:Roche Women Honored as 2009 TWIN Awardees 2Health News:Roche Women Honored as 2009 TWIN Awardees 3Health News:Roche Women Honored as 2009 TWIN Awardees 4Health News:Roche Women Honored as 2009 TWIN Awardees 5
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that ... notice (the "Notice") executed by the Marc S. Hermelin ... requesting that the Board of Directors of the Company ... by written consent relating to the proposed appointment of ... from Ronald J. Kanterman,s departure (the "Director Appointment"). ,, ...
(Date:12/15/2009)... Inc. and Alzheimer,s Weekly today announced the winners of ... designed to help five seniors in their fight to ... five winners will receive a $2,500 Dakim BrainFitness System, ... their brain health and the most widely adopted product ... country. ,, The contest, held to coincide ...
(Date:12/15/2009)... 15 A Harvard medical expert internationally recognized ... the PGA Tour,s decision last month to suspend ... diagnosed him as having the medical condition ... condition is "unreasonable, unfair and discriminatory." ,, ... normal testosterone levels, often referred to informally as ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 75 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest 4788 1Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest 4788 2Updated CDC Travel Health Book Released 52968 1Updated CDC Travel Health Book Released 52968 2Updated CDC Travel Health Book Released 52968 3Study 3A Being active as a preschooler pays off later in childhood 52963 1Study 3A Being active as a preschooler pays off later in childhood 52963 2
... Inc. today announced the presentation of several,scientific studies ... the Annual Meeting of the American Association for ... Los Angeles,California. During this meeting, on Sunday, April ... Onconova was honored as,the recipient of the 2006-2007 ...
... Calif.--(BUSINESS WIRE)--Apr 16, 2007 - Amgen,(Nasdaq:AMGN) today presented ... study evaluating the,efficacy and safety of Aranesp(R) (darbepoetin ... active cancer not receiving,chemotherapy or radiotherapy ("the 103 ... FDA or EMEA in these patients. These,results were ...
Other Medicine Technology:Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles 2Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7
The Storz Protege is an anterior segment unit only....
... phaco system has all the features of ... dependable engineering means minimal maintenance. Small, light ... site to site. Lowest cost reusable tubing ... No longer is there a price objection ...
... The Horizon Phacoemulsification System ... segment surgical system. Lightweight ... high-end performance and features ... It also provides all ...
CataRhex PRO the portable cataract extraction system with automated capsulotomy....
Medicine Products: